American Samoa vs Wallis and Futuna Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology

American Samoa
0.4%
in 2024
Wallis and Futuna Islands
0.4%
in 2024
American Samoa rank
74th
Wallis and Futuna Islands rank
74th

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time

  • American Samoa
  • Wallis and Futuna Islands
00.250.50.751201520192024

How they compare

American Samoa currently reports 0.4% against 0.4% in Wallis and Futuna Islands, a difference of 0.0%.

Across all 10 years both countries report, Wallis and Futuna Islands has been ahead every year.

American Samoa ranks 74th and Wallis and Futuna Islands ranks 74th of 246 countries.

Wallis and Futuna Islands has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade American Samoa Wallis and Futuna Islands Difference Ahead
2010s 0.4% 1.0% 0.6% Wallis and Futuna Islands
2020s 0.5% 0.7% 0.2% Wallis and Futuna Islands

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, American Samoa or Wallis and Futuna Islands?
American Samoa, at 0.4% against 0.4% in Wallis and Futuna Islands as of 2024.
What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between American Samoa and Wallis and Futuna Islands?
0.0%, with American Samoa ahead.
How many years of comparable data are there for American Samoa and Wallis and Futuna Islands?
10 years are reported by both, from 2015 to 2024.
How do American Samoa and Wallis and Futuna Islands rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
American Samoa ranks 74th and Wallis and Futuna Islands ranks 74th of 246 countries.
Where does this data come from?
United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

American Samoa vs Wallis and Futuna Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 10 September 2026, from https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/american-samoa/wallis-and-futuna-islands/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/american-samoa/wallis-and-futuna-islands/">American Samoa vs Wallis and Futuna Islands: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Unit
%
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
250 places, 2,500 data points, 2015–2024
Last refreshed